Related Articles
BONE-MARROW HEMOSIDERIN IRON AND SERUM IRON STATUS MARKERS IN SMALL-CELL CARCINOMA OF THE LUNG
Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer
Serum anti-p53 antibodies in patients with lung cancer.
Age is a prognostic factor affecting survival in lung cancer patients
Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer